Cargando…
One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling
BACKGROUND: Initial serological testing for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection is conducted using either rapid diagnostic tests (RDT) or laboratory-based enzyme immunoassays (EIA)s for detection of hepatitis B surface antigen (HBsAg) or antibodies to HCV (anti-HCV)...
Autores principales: | Parry, John V., Easterbrook, Philippa, Sands, Anita R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688456/ https://www.ncbi.nlm.nih.gov/pubmed/29143611 http://dx.doi.org/10.1186/s12879-017-2774-1 |
Ejemplares similares
-
Diagnostic Accuracy of Point-of-Care HCV Viral Load Assays for HCV Diagnosis: A Systematic Review and Meta-Analysis
por: Tang, Weiming, et al.
Publicado: (2022) -
The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations
por: Huang, Yanfang, et al.
Publicado: (2021) -
Diagnosis of viral hepatitis
por: Easterbrook, Philippa J., et al.
Publicado: (2017) -
Economic evaluations of HBV testing and treatment strategies and applicability to low and middle-income countries
por: Nayagam, Shevanthi, et al.
Publicado: (2017) -
Economic evaluation of HCV testing approaches in low and middle income countries
por: Morgan, Jake R., et al.
Publicado: (2017)